Chief Science Officer
Mark Sussman, Ph.D.
Dr. Mark Sussman is the scientific founder of CardioCreate, and serves as the company’s Chief Scientific Officer. He received his Ph.D. from USC in 1989, followed by post-doctoral work on cardiac biology in the laboratory of Larry Kedes at USC. He is currently a tenured Professor of Biology at San Diego State University and key investigator at the San Diego State University Heart Research Institute. He has authored over 75 peer-review articles and is a popular speaker at national and international venues with over 100 invited presentations in the last 15 years. Dr. Sussman’s research has been supported by grant awards from the National Institutes of Health and the American Heart Association since establishing his independent laboratory in 1995. He was recognized as an Established Investigator of the National American Heart Association in 2000. Dr. Sussman serves on multiple leadership and review committees for the American Heart Association at both affiliate and national organization levels. Dr. Sussman also served as Chair of the study section for Cardiac Contractility, Hypertrophy, and Heart Failure at the National Institutes of Health from as well as a standing member of editorial boards for several journals including Circulation Research, the Journal of Biological Chemistry, the American Journal of Physiology (Heart and Circulatory Physiology), Regenerative Medicine, and the Journal of Molecular and Cellular Cardiology.
Dr. Sussman’s research in the area of myocardial signaling and cardioprotection involving the Akt/PKB pathway led to the discovery of the role of Pim-1 kinsase as a mediator of cardiomyocyte survival and proliferation. This discovery plays a seminal role in CardioCreate’s stem-cell mediated cardiac regeneration technology.